Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
出版年份 2018 全文链接
标题
Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
作者
关键词
Health state utility values (HSUVs), Health-related quality of life (HRQoL), Metastatic non-small cell lung cancer (mNSCLC), Multi-attribute utility instruments (MAUIs), Standard gamble (SG), Time trade-off (TTO), Systematic literature review
出版物
Health and Quality of Life Outcomes
Volume 16, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-12
DOI
10.1186/s12955-018-0994-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values
- (2018) Stavros Petrou et al. PHARMACOECONOMICS
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Health Related Quality of Life in Cancer Immunotherapy: Previously Treated, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
- (2017) J Purchase et al. VALUE IN HEALTH
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) S. Novello et al. ANNALS OF ONCOLOGY
- Health state utilities in non-small cell lung cancer: An international study
- (2016) Beenish Nafees et al. Asia-Pacific Journal of Clinical Oncology
- Caregivers' accuracy in reporting patients' symptom: A preliminary report.
- (2016) Paola Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial
- (2016) Martin Reck et al. Journal of Thoracic Oncology
- Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data
- (2016) Shirin M. Shallwani et al. LUNG CANCER
- Cost-effectiveness analysis of pemetrexed and gemcitabine treatment for advanced nonsmall cell lung cancer in Turkey
- (2016) Pınar YALÇIN BALÇIK et al. Turkish Journal Of Medical Sciences
- A Review of Health State Utility Values Used in UK Nice Appraisals in Advanced NSCLC
- (2016) V Dansk et al. VALUE IN HEALTH
- Measurement of Utilities by Time to Death Related to Advanced Non-Small Cell Lung Cancer in South Korea
- (2016) C Chang et al. VALUE IN HEALTH
- Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review
- (2016) Noman Paracha et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Survival, quality-adjusted survival and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel
- (2015) C J Langer et al. BRITISH JOURNAL OF CANCER
- Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial
- (2015) Domenico Galetta et al. Clinical Lung Cancer
- 3089 Symptom analysis and quality of life (QoL) in patients treated with nivolumab (NIVO) as ≥2nd line therapy for advanced non-small cell lung cancer (aNSCLC)
- (2015) L. Schwartzberg et al. EUROPEAN JOURNAL OF CANCER
- 3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017
- (2015) M. Reck et al. EUROPEAN JOURNAL OF CANCER
- Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer
- (2015) Silvia Novello et al. EUROPEAN JOURNAL OF CANCER
- Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
- (2015) R. Lal et al. LUNG CANCER
- Health Related Quality Of Life Of Caregivers And Patients Treated For Metastatic Non-Small Cell Lung Cancer (Nsclc) With Oral Vinorelbine
- (2015) H Linnet et al. VALUE IN HEALTH
- KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
- (2014) Marie Westwood et al. HEALTH TECHNOLOGY ASSESSMENT
- Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non–Small-Cell Lung Cancer
- (2014) Fiona Blackhall et al. Journal of Thoracic Oncology
- Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: Adjusting quality-of-life and lead-time bias for utility of surgery
- (2014) Szu-Chun Yang et al. LUNG CANCER
- The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network
- (2014) Lucía Cea Soriano et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib
- (2014) Ingolf Griebsch et al. BMJ Open
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Symptom and Quality of Life Benefit of Afatinib in Advanced Non–Small-Cell Lung Cancer Patients Previously Treated with Erlotinib or Gefitinib: Results of a Randomized Phase IIb/III Trial (LUX-Lung 1)
- (2013) Vera Hirsh et al. Journal of Thoracic Oncology
- Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting
- (2013) Christos Chouaid et al. Journal of Thoracic Oncology
- Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany
- (2013) Shrividya Iyer et al. LUNG CANCER
- A Systematic Review of Utility Values for Chemotherapy-Related Adverse Events
- (2013) Fatiha H. Shabaruddin et al. PHARMACOECONOMICS
- Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer
- (2013) Bradley J. Barney et al. QUALITY OF LIFE RESEARCH
- Systematic Searching and Selection of Health State Utility Values from the Literature
- (2013) Diana Papaioannou et al. VALUE IN HEALTH
- Health State Utility Values in Advanced Non-Small Cell Lung Cancer Patients
- (2013) J. Chevalier et al. VALUE IN HEALTH
- Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life
- (2012) Wolfgang Schuette et al. BMC CANCER
- Interim Data from the Medical Research Council QUARTZ Trial: Does Whole Brain Radiotherapy Affect the Survival and Quality of Life of Patients with Brain Metastases from Non-small Cell Lung Cancer?
- (2012) R.E. Langley et al. CLINICAL ONCOLOGY
- Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2012) Cesare Gridelli et al. Journal of Thoracic Oncology
- PCN25 Utility of Advanced Non-Small Cell Lung Cancer Patients in Thailand: Preliminary Study
- (2012) P. Tongpak et al. VALUE IN HEALTH
- Cost Effectiveness of Personalized Therapy for First-Line Treatment of Stage IV and Recurrent Incurable Adenocarcinoma of the Lung
- (2012) Elizabeth A. Handorf et al. Journal of Oncology Practice
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
- (2011) PA Bradbury et al. VALUE IN HEALTH
- PCN142 EVALUATION OF THE QUALITY OF LIFE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WHO FAILED TO FIRST LINE CHEMOTHERAPY IN TREATMENT WITH ERLOTINIB VS TAXANES
- (2011) J Vargas et al. VALUE IN HEALTH
- PCN94 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN A REAL LIFE SETTING: BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB BASED THERAPY IN A EUROPEAN PILOT STUDY
- (2011) C. Chouaid et al. VALUE IN HEALTH
- PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO
- (2011) W. Chen et al. VALUE IN HEALTH
- Health outcomes in economic evaluation: the QALY and utilities
- (2010) S. J. Whitehead et al. BRITISH MEDICAL BULLETIN
- Derivation of Utility Values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 Questionnaire Values in Lung Cancer
- (2010) Raymond W. Jang et al. Journal of Thoracic Oncology
- Significance of the Presence of Microscopic Vascular Invasion After Complete Resection of Stage I–II pT1-T2N0 Non-small Cell Lung Cancer and Its Relation with T-Size Categories: Did the 2009 7th Edition of the TNM Staging System Miss Something?
- (2010) Enrico Ruffini et al. Journal of Thoracic Oncology
- A Review and Meta-Analysis of Utility Values for Lung Cancer
- (2010) Julie Sturza MEDICAL DECISION MAKING
- Importance of Quality of Life in Patients with Non–Small-Cell Lung Cancer
- (2009) Carlos Camps et al. Clinical Lung Cancer
- Improving Health-Related Quality of Life in Non–Small-Cell Lung Cancer with Current Treatment Options
- (2008) David F. Cella et al. Clinical Lung Cancer
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Health state utilities for non small cell lung cancer
- (2008) Beenish Nafees et al. Health and Quality of Life Outcomes
- Health state utility scores in advanced non-small cell lung cancer
- (2008) Scott Doyle et al. LUNG CANCER
- Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations
- (2008) Andrew Lloyd et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now